Fig. 8.
![Fig. 8. Flow cytometry analysis of recombinant Oeaalloantigen. / (A) Binding of non-LIBS mAb Gi5 to stable transfectants expressing Pro33 (Oea [+]; black curve) and Pro33 ΔLys611 (Oea −; gray). (B) Binding of anti-LIBS mAb D3 to both stable transfectants in the presence of RGEW or RGDW peptides. (C) Binding of ligand-mimetic mAb PAC-1 to untreated and DTT-treated “activated” transfectants.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/99/4/10.1182_blood.v99.4.1205/6/h80422165008.jpeg?Expires=1725494577&Signature=JjN~lAhyPcoXLxy02Q1eqS3swr1KOModW9~6HOlQwuD1ZSFfepURVyXtnovsNnkN9WCj6Q5KcTD4b3Qy5wmqvKkXI1GiH8bkrBj09Op8eXGthWl465FM-3~~Cwf3Npvy2UVP~HziFrlmk~xHTRZ10nMszY5e5u11PJFKXyuXCF~JtO~o6M-gH7-zOWSO0UCDi0rimTWYHnETewq98x9c8AHojfLl4u6AUDTFeSGiqmCFJOFF1jm5ceRwd0AfJcMBuMV90b4e-trxYpLfu87yQ~iqB2rY79W11wu-BmVjeRn0VqXBroHJuUBbI0TsfwrokYLbwpDXFpjPGByQepX0dw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Flow cytometry analysis of recombinant Oeaalloantigen.
(A) Binding of non-LIBS mAb Gi5 to stable transfectants expressing Pro33 (Oea [+]; black curve) and Pro33 ΔLys611 (Oea −; gray). (B) Binding of anti-LIBS mAb D3 to both stable transfectants in the presence of RGEW or RGDW peptides. (C) Binding of ligand-mimetic mAb PAC-1 to untreated and DTT-treated “activated” transfectants.
